Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 859383, 12 pages
http://dx.doi.org/10.1155/2015/859383
Research Article

Mechanisms of Thymoquinone Hepatorenal Protection in Methotrexate-Induced Toxicity in Rats

1Department of Pharmacology, Faculty of Medicine, Minia University, El-Minia 61511, Egypt
2Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia
3Department of Biochemistry, Faculty of Medicine, Minia University, El-Minia 61511, Egypt
4Department of Histology, Faculty of Medicine, Minia University, El-Minia 61511, Egypt

Received 9 January 2015; Revised 5 May 2015; Accepted 13 May 2015

Academic Editor: Giuseppe Valacchi

Copyright © 2015 Azza A. K. El-Sheikh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. C. Widemann and P. C. Adamson, “Understanding and managing methotrexate nephrotoxicity,” The Oncologist, vol. 11, no. 6, pp. 694–703, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Morsy, S. A. Ibrahim, E. F. Amin, M. Y. Kamel, R. A. Rifaai, and M. K. Hassan, “Curcumin ameliorates methotrexate-induced nephrotoxicity in rats,” Advances in Pharmacological Sciences, vol. 2013, Article ID 387071, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. A. K. El-Sheikh, J. J. M. W. van den Heuvel, J. B. Koenderink, and F. G. M. Russel, “Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport,” The Journal of Pharmacology and Experimental Therapeutics, vol. 320, no. 1, pp. 229–235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. M. Yeo, V. H. Chong, A. Earnest, and W. L. Yang, “Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis,” World Journal of Hepatology, vol. 5, no. 5, pp. 275–280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Ahmad, A. Husain, M. Mujeeb et al., “A review on therapeutic potential of Nigella sativa: a miracle herb,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 5, pp. 337–352, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Randhawa and M. S. Alghamdi, “Anticancer activity of Nigella sativa (Black Seed)—a review,” The American Journal of Chinese Medicine, vol. 39, no. 6, pp. 1075–1091, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Awad, R. Kamel, and M.-A. E. Sherief, “Effect of thymoquinone on hepatorenal dysfunction and alteration of CYP3A1 and spermidine/spermine N-1-acetyl-transferase gene expression induced by renal ischaemia-reperfusion in rats,” The Journal of Pharmacy and Pharmacology, vol. 63, no. 8, pp. 1037–1042, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Ibrahim, A. A. K. El-Sheikh, H. M. Khalaf, and A. M. Abdelrahman, “Protective effect of peroxisome proliferator activator receptor (PPAR)-α and -γ Ligands against methotrexate-induced nephrotoxicity,” Immunopharmacology and Immunotoxicology, vol. 36, no. 2, pp. 130–137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Buege and S. D. Aust, “Microsomal lipid peroxidation,” Methods in Enzymology, vol. 52, pp. 302–310, 1978. View at Publisher · View at Google Scholar · View at Scopus
  10. K. V. H. Sastry, R. P. Moudgal, J. Mohan, J. S. Tyagi, and G. S. Rao, “Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy,” Analytical Biochemistry, vol. 306, no. 1, pp. 79–82, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Çakir, E. Özkan, E. Dulundu et al., “Caffeic acid phenethyl ester (CAPE) prevents methotrexate-induced hepatorenal oxidative injury in rats,” Journal of Pharmacy and Pharmacology, vol. 63, no. 12, pp. 1566–1571, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Mukherjee, S. Ghosh, S. Choudhury et al., “Pomegranate reverses methotrexate-induced oxidative stress and apoptosis in hepatocytes by modulating Nrf2-NF-κB pathways,” The Journal of Nutritional Biochemistry, vol. 24, no. 12, pp. 2040–2050, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Vardi, H. Parlakpinar, B. Ates, A. Cetin, and A. Otlu, “The protective effects of Prunus armeniaca L (apricot) against methotrexate-induced oxidative damage and apoptosis in rat kidney,” Journal of Physiology and Biochemistry, vol. 69, no. 3, pp. 371–381, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Ali, S. Rashid, S. Nafees, S. K. Hasan, and S. Sultana, “Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis,” Molecular and Cellular Biochemistry, vol. 385, no. 1-2, pp. 215–223, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. I. I. Severina, F. F. Severin, G. A. Korshunova et al., “In search of novel highly active mitochondria-targeted antioxidants: thymoquinone and its cationic derivatives,” FEBS Letters, vol. 587, no. 13, pp. 2018–2024, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Uz, F. Öktem, H. R. Yilmaz, E. Uzar, and F. Özgüner, “The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: protective effect of caffeic acid phenethyl ester,” Molecular and Cellular Biochemistry, vol. 277, no. 1-2, pp. 165–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. F. C. Leitão, G. A. C. Brito, R. B. Oriá et al., “Role of inducible nitric oxide synthase pathway on methotrexate-induced intestinal mucositis in rodents,” BMC Gastroenterology, vol. 11, article 90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Yang, J.-S. Kim, J. Kim et al., “Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer,” Brain Research Bulletin, vol. 89, no. 1-2, pp. 50–56, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. G. Neuman, R. G. Cameron, J. A. Haber, G. G. Katz, I. M. Malkiewicz, and N. H. Shear, “Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytotoxicity,” Clinical Biochemistry, vol. 32, no. 7, pp. 519–536, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. L. J. Crofford, B. Tan, C. J. McCarthy, and T. Hla, “Involvement of nuclear factor κB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes,” Arthritis and Rheumatism, vol. 40, no. 2, pp. 226–236, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Küper, F.-X. Beck, and W. Neuhofer, “Toll-like receptor 4 activates NF-kappaB and MAP kinase pathways to regulate expression of proinflammatory COX-2 in renal medullary collecting duct cells,” The American Journal of Physiology—Renal Physiology, vol. 302, no. 1, pp. F38–F46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-S. Zhao, F.-S. Zhu, S. Liu, C.-Q. Yang, and X.-M. Chen, “Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats,” Chinese Medical Journal, vol. 125, no. 13, pp. 2316–2321, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. O. M. Omran, “Effects of thymoquinone on STZ-induced diabetic nephropathy: an immunohistochemical study,” Ultrastructural Pathology, vol. 38, no. 1, pp. 26–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. M. Sayed-Ahmed and M. N. Nagi, “Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 5-6, pp. 399–405, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Basarslan, N. Yilmaz, S. Ates et al., “Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats,” Human and Experimental Toxicology, vol. 31, no. 7, pp. 726–733, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. F. Zafeer, M. Waseem, S. Chaudhary, and S. Parvez, “Cadmium-induced hepatotoxicity and its abrogation by thymoquinone,” Journal of Biochemical and Molecular Toxicology, vol. 26, no. 5, pp. 199–205, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Ö. Aycan, A. Tüfek, O. Tokgöz et al., “Thymoquinone treatment against acetaminophen-induced hepatotoxicity in rats,” International Journal of Surgery, vol. 12, no. 3, pp. 213–218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. G. M. Suddek, “Protective role of thymoquinone against liver damage induced by tamoxifen in female rats,” Canadian Journal of Physiology and Pharmacology, vol. 92, no. 8, pp. 640–644, 2014. View at Publisher · View at Google Scholar
  29. A. L. Al-Malki and A. A. Sayed, “Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa-β,” BMC Complementary and Alternative Medicine, vol. 14, article 282, 2014. View at Publisher · View at Google Scholar
  30. A. Nili-Ahmadabadi, F. Tavakoli, G. R. Hasanzadeh, H. R. Rahimi, and O. Sabzevari, “Protective effect of pretreatment with thymoquinone against Aflatoxin B1 induced liver toxicity in mice,” Daru, vol. 19, no. 4, pp. 282–287, 2011. View at Google Scholar · View at Scopus
  31. C. Sankaranarayanan and L. Pari, “Thymoquinone ameliorates chemical induced oxidative stress and β-cell damage in experimental hyperglycemic rats,” Chemico-Biological Interactions, vol. 190, no. 2-3, pp. 148–154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Gökçe, S. Oktar, A. Koc, and Z. Yonden, “Protective effects of thymoquinone against methotrexate-induced testicular injury,” Human & Experimental Toxicology, vol. 30, no. 8, pp. 897–903, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Ragheb, A. Attia, W. S. Eldin, F. Elbarbry, S. Gazarin, and A. Shoker, “The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent, against renal injury: a review,” Saudi Journal of Kidney Diseases and Transplantation, vol. 20, no. 5, pp. 741–752, 2009. View at Google Scholar · View at Scopus
  34. M. N. Nagi, H. A. Almakki, M. M. Sayed-Ahmed, and A. M. Al-Bekairi, “Thymoquinone supplementation reverses acetaminophen-induced oxidative stress, nitric oxide production and energy decline in mice liver,” Food and Chemical Toxicology, vol. 48, no. 8-9, pp. 2361–2365, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. A. R. Sayed, “ThymoIuinone and proanthocyanidin attenuation of diabetic nephropathy in rats,” European Review for Medical and Pharmacological Sciences, vol. 16, no. 6, pp. 808–815, 2012. View at Google Scholar · View at Scopus
  36. G. K. Helal, “Thymoquinone supplementation ameliorates acute endotoxemia-induced liver dysfunction in rats,” Pakistan Journal of Pharmaceutical Sciences, vol. 23, no. 2, pp. 131–137, 2010. View at Google Scholar · View at Scopus
  37. S. Attoub, O. Sperandio, H. Raza et al., “Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo,” Fundamental & Clinical Pharmacology, vol. 27, no. 5, pp. 557–569, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Rajput, B. N. P. Kumar, S. Sarkar et al., “Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer,” PLoS ONE, vol. 8, no. 4, Article ID e61342, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Taye and A. A. K. El-Sheikh, “Lectin-like oxidized low-density lipoprotein receptor 1 pathways,” European Journal of Clinical Investigation, vol. 43, no. 7, pp. 740–745, 2013. View at Publisher · View at Google Scholar · View at Scopus